(19)
(11) EP 2 135 075 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
12.04.2017 Bulletin 2017/15

(45) Mention of the grant of the patent:
26.10.2016 Bulletin 2016/43

(21) Application number: 08719049.2

(22) Date of filing: 20.03.2008
(51) International Patent Classification (IPC): 
G01N 33/49(2006.01)
G01N 33/72(2006.01)
 G01N 33/92(2006.01)
(86) International application number:
PCT/GB2008/050204
(87) International publication number:
WO 2008/114060 (25.09.2008 Gazette 2008/39)

(54)

WHOLE BLOOD ASSAY

VOLLBLUT-TESTVERFAHREN

ANALYSE DE SANG TOTAL

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30) Priority: 22.03.2007 GB 0705495

(43) Date of publication of application:
23.12.2009 Bulletin 2009/52

(73) Proprietor: EKF-Diagnostic GmbH
39179 Barleben/Magdeburg (DE)

(72) Inventors:
  • VESSEY, John Phillip
    East Horsley Surrey KT24 5BT (GB)
  • GRAY, Adrian Richard
    Wokingham Berkshire RG41 3AU (GB)
  • PERCIVAL, David
    Chester Flintshire CH5 3HS (GB)

(74) Representative: Gramm, Lins & Partner Patent- und Rechtsanwälte PartGmbB 
Theodor-Heuss-Straße 1
38122 Braunschweig
38122 Braunschweig (DE)


(56) References cited: : 
EP-A- 1 037 048
EP-A- 1 486 778
WO-A-2005/018443
WO-A-2006/109279
US-A1- 2006 281 187
 EP-A- 1 467 206
WO-A-01/57510
WO-A-2006/090154
US-A1- 2005 267 346
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).